Cynosure Announces New CEO and Other Key Leadership Additions

Cynosure develops, manufactures, and markets aesthetic treatment systems. Photo credit: Cynosure

Cynosure announced new leadership appointments to help accelerate the company's business transformation and growth plans. Todd Tillemans is now CEO. He is the former president of Hershey's flagship U.S. business, and before that he held various leadership positions across Unilever's skin and personal care portfolio where he helped build powerful global personal care brands, including Dove, Axe, Vaseline, Ponds, and Degree. "Todd is an inspiring executive with demonstrated success building diverse and talented executive teams and motivating them to achieve transformational success," says Sandi Peterson, chairman of Cynosure and Clayton, Dubilier & Rice Operating Partner. "He understands that sustainable growth is the product of sound strategic vision, innovative consumer insight, and a passion for executional excellence."

In other leadership developments, Cynosure announced that Jorge Pinedo, former senior vice president at Johnson & Johnson, will join the company as executive vice president of international, to lead the company's growth initiatives across global geographies. The company also appointed Cynosure's former chairman and CEO, Michael Davin, to the board of directors, along with Michelle Freyre, former president of Johnson & Johnson's U.S. Beauty business. "We are very pleased to welcome each of these talented and high-energy executives to the Cynosure team," says CD&R partner, Derek Strum. "Todd brings an incredible track record of building global businesses; Jorge adds extensive international experience in consumer medtech; Michael offers valuable industry expertise from his highly successful tenure at Cynosure; and Michelle provides deep experience with global beauty brands. We are extremely fortunate to add their collective experience to the company's leadership." 


Elizabeth Grady Partners With Cynosure To Offer Innovative Treatments

CD&R to Acquire Cynosure From Hologic

Sofwave Medical’s Ultrasound Technology Receives FDA Clearance